semaglutide mash fda approval The has granted accelerated for Wegovy (semaglutide 2.4 mg) to treat adults with noncirrhotic and moderate to advanced liver fibrosis, marking the first GLP-1 therapy approved for MASH, based Novo's Wegovy becomes first GLP-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30




























